Twin Tree Management’s Novo Nordisk NVO Stock Holding History

Twin Tree Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-470,200	Closed	-$26.1M	–	1628
2025 Q3	$26.1M	Sell	470,200 -190,800	-29%	-$11.2M	0.11%	219
2025 Q2	$45.6M	Buy	661,000 +386,600	+141%	+$26.3M	0.09%	233
2025 Q1	$19.1M	Sell	274,400 -27,000	-9%	-$2.23M	0.04%	449
2024 Q4	$25.9M	Sell	301,400 -167,200	-36%	-$18.1M	0.05%	375
2024 Q3	$55.8M	Buy	468,600 +395,500	+541%	+$52.7M	0.11%	147
2024 Q2	$10.4M	Buy	73,100 +34,200	+88%	+$4.53M	0.02%	568
2024 Q1	$4.99M	Sell	38,900 -667,400	-94%	-$79.4M	0.01%	812
2023 Q4	$73.1M	Sell	706,300 -240,900	-25%	-$23.8M	0.14%	138
2023 Q3	$86.1M	Buy	+947,200	New	+$83.4M	0.19%	96
2023 Q2	–	Sell	-105,600	Closed	-$8.4M	–	1444
2023 Q1	$8.4M	Sell	105,600 -354,400	-77%	-$25.1M	0.02%	616
2022 Q4	$31.1M	Buy	460,000 +10,000	+2%	+$586K	0.07%	271
2022 Q3	$22.4M	Sell	450,000 -715,200	-61%	-$38.3M	0.04%	354
2022 Q2	$64.9M	Sell	1,165,200 -442,600	-28%	-$24.6M	0.1%	133
2022 Q1	$89.3M	Buy	1,607,800 +999,200	+164%	+$51.3M	0.14%	109
2021 Q4	$34.1M	Buy	608,600 +562,800	+1,229%	+$30.5M	0.07%	257
2021 Q3	$2.2M	Hold	45,800	–	–	﹤0.01%	1011
2021 Q2	$1.92M	Buy	45,800 +38,000	+487%	+$1.47M	0.01%	894
2021 Q1	$263K	Sell	7,800 -43,600	-85%	-$1.55M	﹤0.01%	1120
2020 Q4	$1.79M	Buy	+51,400	New	+$1.78M	0.01%	879
2020 Q2	–	Sell	-44,600	Closed	-$1.34M	–	1633
2020 Q1	$1.34M	Buy	+44,600	New	+$1.33M	0.01%	797
2019 Q2	–	Sell	-143,400	Closed	-$3.75M	–	1473
2019 Q1	$3.75M	Sell	143,400 -281,800	-66%	-$6.93M	0.02%	511
2018 Q4	$9.79M	Buy	425,200 +371,400	+690%	+$8.25M	0.06%	321
2018 Q3	$1.27M	Buy	+53,800	New	+$1.31M	0.01%	677
2018 Q1	–	Sell	-321,600	Closed	-$8.63M	–	1248
2017 Q4	$8.63M	Buy	321,600 +119,200	+59%	+$3.03M	0.06%	269
2017 Q3	$4.87M	Sell	202,400 -366,000	-64%	-$8.27M	0.04%	381
2017 Q2	$12.2M	Buy	568,400 +535,600	+1,633%	+$10.8M	0.1%	208
2017 Q1	$562K	Buy	+32,800	New	+$571K	0.01%	762
2016 Q4	–	Sell	-22,800	Closed	-$474K	–	1305
2016 Q3	$474K	Buy	+22,800	New	+$565K	0.01%	834
2016 Q2	–	Sell	-60,800	Closed	-$1.65M	–	1349
2016 Q1	$1.65M	Buy	+60,800	New	+$1.63M	0.03%	460
2015 Q4	–	Sell	-4,000	Closed	-$108K	–	1521
2015 Q3	$108K	Sell	4,000 -17,200	-81%	-$487K	﹤0.01%	1097
2015 Q2	$580K	Sell	21,200 -17,000	-45%	-$478K	0.01%	818
2015 Q1	$1.02M	Buy	+38,200	New	+$880K	0.03%	582
2014 Q2	–	Sell	-177,600	Closed	-$4.05M	–	992
2014 Q1	$4.05M	Buy	177,600 +128,600	+262%	+$2.74M	0.08%	281
2013 Q4	$905K	Sell	49,000 -128,000	-72%	-$2.23M	0.02%	621
2013 Q3	$3M	Sell	177,000 -163,000	-48%	-$2.74M	0.1%	218
2013 Q2	$5.27M	Buy	+340,000	New	+$5.66M	0.2%	78

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Twin Tree Management's NVO Position: Q4 2025 in Review

Twin Tree Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 5,626 shares — an estimated $312K sold.

Twin Tree Management first reported a position in NVO in Q2 2013 and held it in 32 quarters. The position peaked at $25.6M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Twin Tree Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
Twin Tree Management sold 5,626 Novo Nordisk shares in Q4 2025, an estimated $312K.
Twin Tree Management first reported a position in Novo Nordisk in Q2 2013 and held it in 32 quarters.
Twin Tree Management's Novo Nordisk position peaked at $25.6M in Q2 2024.
1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.